Clinical Trials
11 trialsNCT07458347 2026-05-12
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Phase 1 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT06084689 2025-09-02
EMPIRE
Institut Bergonié
Phase 2 Withdrawn
NCT04566614 2025-04-06
PREVAILctDNA
Royal Marsden NHS Foundation Trust
Completed
NCT05517811 2025-01-28
TEG
University of Colorado, Denver
Recruiting
NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT04907864 2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2 Unknown
NCT03411200 2020-07-14
PACE-Mobil
Herlev and Gentofte Hospital
Phase NA Completed
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT02988635 2016-12-09
Early Palliative Care on Quality of Life of Advanced Cancer Patients
Azienda Ospedaliero-Universitaria di Parma
Phase 3 Completed